Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world outcomes.

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations ...

The diagnostic category of adult ADHD is becoming more inclusive. That’s not the same as it being overdiagnosed ...

U.S health officials are updating the prescribing labels of long-acting ADHD medications to carry new warnings for children ...

ADHD Advisor examines why ADHD often goes undiagnosed in women and girls, and how gender biases in symptoms and diagnosis continue to shape outcomes.

Undiagnosed ADHD, especially in women, can heighten the risk of substance abuse. Experts explain how emotional dysregulation ...

ADHD is covered under the American Disabilities Act, which prohibits employers from disqualifying you from a position due to the condition. Other countries, like Canada and the United Kingdom ...